limertinib, 100mg

limertinib, 100mg

XST-14, 25mg

XST-14, 25mg

XST-14, 5mg

1.501,78 RON
SKU
SKM_E1750_5mg

XST-14 is a potent, competitive, and highly selective inhibitor of ULK1and exhibits an IC50 of 26.6 nM in an in vitro ULK1 kinase activity assay, respectively. XST-14 reduces the phosphorylation of the ULK1 downstream substrate and induces autophagy inhibition. It exhibits antitumor effects.

Mai multe informatii
Price 1.262,00 RON (preturile sunt fara TVA)
Description

XST-14 is a potent, competitive, and highly selective inhibitor of ULK1and exhibits an IC50 of 26.6 nM in an in vitro ULK1 kinase activity assay, respectively. XST-14 reduces the phosphorylation of the ULK1 downstream substrate and induces autophagy inhibition. It exhibits antitumor effects.